Biotech

All Articles

Novo inks $600M NanoVation bargain to examine genetic medications ex-liver

.Novo Nordisk is actually continuing its push right into genetic medicines, consenting to compensate...

Innovent links cytokine to colorectal cancer reactions

.Innovent Biologics has made the case that its own gate inhibitor-cytokine combination healthy prote...

Merck, Daiichi ADC strikes objective in stage 3 bronchi cancer cells research study

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens artificial intelligence focus along with collab to pick cancer cells targets

.Five months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a possible risk to BioMarin's Voxzogo, reporting stage 3 de...

Despite ph. 3 overlook, Alkeus finds course ahead for eye illness possession

.Though Alkeus Pharmaceuticals' oral eye ailment property failed to dramatically lessen geographic d...

Kairos goes public with $6M IPO to finance trials of cancer cells medication

.Along with a triad of biotechs striking the Nasdaq on Friday, it was quick and easy to miss a small...

Vaccine and also Keytruda combo reliable in squamous tissue cancer

.Invulnerable checkpoint preventions are the superheroes of cancer cells treatment. Medicines like B...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as...

Regeneron's Opdualag opponent shows 57% reaction fee

.Regeneron is actually back along with long-term follow-up for its LAG-3 prevention and also PD-1 pr...